Upstream Bio (UPB) insider trading in the last 6 months
5 insiders sold $58K. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Upstream Bio
Questions about UPB's insider trades
Are UPB insiders buying or selling?
5 insiders sold $58K across 10 filings in the last 6 months. No open-market buys on record. The newest filing: Everett Rand Sutherland, Chief Executive Officer, sold $12K on Sep 16, 2026.
Who are UPB's biggest insider sellers?
By the dollars of their sales in the last 6 months: Everett Rand Sutherland (Chief Executive Officer), 2 sales; Aaron Deykin (Chief Medical Officer), 2 sales; Michael Gray (CFO and COO), 2 sales. 5 insiders sold in all.
When did a UPB insider last buy?
No UPB insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Everett Rand Sutherland on Sep 16, 2026.
Upstream Bio's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.